- call +1-201-465-4211
- email sales@mrinsights.biz
Rho associated coiled-coil containing protein kinase 2 is a protein that in humans is encoded by the ROCK2 gene. The protein encoded by this gene is a serine/threonine kinase that regulates cytokinesis, smooth muscle contraction, the formation of actin stress fibers and focal adhesions, and the activation of the c-fos serum response element. This protein, which is an isozyme of ROCK1, is a target for the small GTPase Rho.
Scope of the Report:
In the last several years, global market of Rho Associated Protein Kinase 2 developed rapidly, with an average growth rate of 68%. In 2017, Global Market Size of Rho Associated Protein Kinase 2 is nearly 850 K USD.
For developing product, there are 1 product in Phase 3, 2 products in Phase 2, 0 products in Phase 1 and 6 products in Preclinical. The total investment for Rho Associated Protein Kinase 2 developing is around 88 M USD in 2017.
The Application of Rho Associated Protein Kinase 2 includes Glaucoma, Spinal Cord, Chronic Obstructive Pulmonary Disease, Immune Therapy and Others, and the proportion of R&D Investmen for Glaucoma in 2017 is about 67%, and the proportion is in decrease trend from 2012 to 2016.
The worldwide market for Rho Associated Protein Kinase 2 is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Rho Associated Protein Kinase 2 in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Aerie Pharmaceuticals
Kadmon Corporation
BioAxone BioSciences Inc
Redx Pharma
Angion Biomedica
DWTI
HitGen LTD
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Type I
Type II
Market Segment by Applications, can be divided into
Glaucoma
Spinal Cord
Chronic Obstructive Pulmonary Disease
Immune Therapy
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rho Associated Protein Kinase 2 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Rho Associated Protein Kinase 2, with price, sales, revenue and global market share of Rho Associated Protein Kinase 2 in 2017 and 2018.
Chapter 3, the Rho Associated Protein Kinase 2 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rho Associated Protein Kinase 2 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Rho Associated Protein Kinase 2 market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Rho Associated Protein Kinase 2 sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Rho Associated Protein Kinase 2 Introduction
1.2 Market Analysis by Type
1.2.1 Type I
1.2.2 Type II
1.3 Market Analysis by Applications
1.3.1 Glaucoma
1.3.2 Spinal Cord
1.3.3 Chronic Obstructive Pulmonary Disease
1.3.4 Immune Therapy
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Aerie Pharmaceuticals
2.1.1 Business Overview
2.1.2 Rho Associated Protein Kinase 2 Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Aerie Pharmaceuticals Rho Associated Protein Kinase 2 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Kadmon Corporation
2.2.1 Business Overview
2.2.2 Rho Associated Protein Kinase 2 Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Kadmon Corporation Rho Associated Protein Kinase 2 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 BioAxone BioSciences Inc
2.3.1 Business Overview
2.3.2 Rho Associated Protein Kinase 2 Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BioAxone BioSciences Inc Rho Associated Protein Kinase 2 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Redx Pharma
2.4.1 Business Overview
2.4.2 Rho Associated Protein Kinase 2 Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Redx Pharma Rho Associated Protein Kinase 2 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Angion Biomedica
2.5.1 Business Overview
2.5.2 Rho Associated Protein Kinase 2 Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Angion Biomedica Rho Associated Protein Kinase 2 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 DWTI
2.6.1 Business Overview
2.6.2 Rho Associated Protein Kinase 2 Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 DWTI Rho Associated Protein Kinase 2 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 HitGen LTD
2.7.1 Business Overview
2.7.2 Rho Associated Protein Kinase 2 Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 HitGen LTD Rho Associated Protein Kinase 2 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Rho Associated Protein Kinase 2 Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Rho Associated Protein Kinase 2 Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Rho Associated Protein Kinase 2 Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Rho Associated Protein Kinase 2 Manufacturer Market Share in 2018
3.3.2 Top 6 Rho Associated Protein Kinase 2 Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Rho Associated Protein Kinase 2 Market Analysis by Regions
4.1 Global Rho Associated Protein Kinase 2 Sales, Revenue and Market Share by Regions
4.1.1 Global Rho Associated Protein Kinase 2 Sales and Market Share by Regions (2014-2019)
4.1.2 Global Rho Associated Protein Kinase 2 Revenue and Market Share by Regions (2014-2019)
4.2 North America Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
4.3 Europe Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
4.5 South America Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
5 North America Rho Associated Protein Kinase 2 by Country
5.1 North America Rho Associated Protein Kinase 2 Sales, Revenue and Market Share by Country
5.1.1 North America Rho Associated Protein Kinase 2 Sales and Market Share by Country (2014-2019)
5.1.2 North America Rho Associated Protein Kinase 2 Revenue and Market Share by Country (2014-2019)
5.2 United States Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
5.3 Canada Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
5.4 Mexico Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
6 Europe Rho Associated Protein Kinase 2 by Country
6.1 Europe Rho Associated Protein Kinase 2 Sales, Revenue and Market Share by Country
6.1.1 Europe Rho Associated Protein Kinase 2 Sales and Market Share by Country (2014-2019)
6.1.2 Europe Rho Associated Protein Kinase 2 Revenue and Market Share by Country (2014-2019)
6.2 Germany Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
6.3 UK Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
6.4 France Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
6.5 Russia Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
6.6 Italy Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
7 Asia-Pacific Rho Associated Protein Kinase 2 by Country
7.1 Asia-Pacific Rho Associated Protein Kinase 2 Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Rho Associated Protein Kinase 2 Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Rho Associated Protein Kinase 2 Revenue and Market Share by Country (2014-2019)
7.2 China Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
7.3 Japan Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
7.4 Korea Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
7.5 India Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
8 South America Rho Associated Protein Kinase 2 by Country
8.1 South America Rho Associated Protein Kinase 2 Sales, Revenue and Market Share by Country
8.1.1 South America Rho Associated Protein Kinase 2 Sales and Market Share by Country (2014-2019)
8.1.2 South America Rho Associated Protein Kinase 2 Revenue and Market Share by Country (2014-2019)
8.2 Brazil Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
8.3 Argentina Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
8.4 Colombia Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
9 Middle East and Africa Rho Associated Protein Kinase 2 by Countries
9.1 Middle East and Africa Rho Associated Protein Kinase 2 Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Rho Associated Protein Kinase 2 Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Rho Associated Protein Kinase 2 Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
9.3 Turkey Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
9.4 Egypt Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
9.5 Nigeria Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
9.6 South Africa Rho Associated Protein Kinase 2 Sales and Growth Rate (2014-2019)
10 Global Rho Associated Protein Kinase 2 Market Segment by Type
10.1 Global Rho Associated Protein Kinase 2 Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Rho Associated Protein Kinase 2 Sales and Market Share by Type (2014-2019)
10.1.2 Global Rho Associated Protein Kinase 2 Revenue and Market Share by Type (2014-2019)
10.2 Type I Sales Growth and Price
10.2.1 Global Type I Sales Growth (2014-2019)
10.2.2 Global Type I Price (2014-2019)
10.3 Type II Sales Growth and Price
10.3.1 Global Type II Sales Growth (2014-2019)
10.3.2 Global Type II Price (2014-2019)
11 Global Rho Associated Protein Kinase 2 Market Segment by Application
11.1 Global Rho Associated Protein Kinase 2 Sales Market Share by Application (2014-2019)
11.2 Glaucoma Sales Growth (2014-2019)
11.3 Spinal Cord Sales Growth (2014-2019)
11.4 Chronic Obstructive Pulmonary Disease Sales Growth (2014-2019)
11.5 Immune Therapy Sales Growth (2014-2019)
11.6 Others Sales Growth (2014-2019)
12 Rho Associated Protein Kinase 2 Market Forecast (2019-2024)
12.1 Global Rho Associated Protein Kinase 2 Sales, Revenue and Growth Rate (2019-2024)
12.2 Rho Associated Protein Kinase 2 Market Forecast by Regions (2019-2024)
12.2.1 North America Rho Associated Protein Kinase 2 Market Forecast (2019-2024)
12.2.2 Europe Rho Associated Protein Kinase 2 Market Forecast (2019-2024)
12.2.3 Asia-Pacific Rho Associated Protein Kinase 2 Market Forecast (2019-2024)
12.2.4 South America Rho Associated Protein Kinase 2 Market Forecast (2019-2024)
12.2.5 Middle East and Africa Rho Associated Protein Kinase 2 Market Forecast (2019-2024)
12.3 Rho Associated Protein Kinase 2 Market Forecast by Type (2019-2024)
12.3.1 Global Rho Associated Protein Kinase 2 Sales Forecast by Type (2019-2024)
12.3.2 Global Rho Associated Protein Kinase 2 Market Share Forecast by Type (2019-2024)
12.4 Rho Associated Protein Kinase 2 Market Forecast by Application (2019-2024)
12.4.1 Global Rho Associated Protein Kinase 2 Sales Forecast by Application (2019-2024)
12.4.2 Global Rho Associated Protein Kinase 2 Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Rho Associated Protein Kinase 2 Picture
Table Product Specifications of Rho Associated Protein Kinase 2
Figure Global Sales Market Share of Rho Associated Protein Ki
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
